A detailed analysis of risk factors including genomic markers of women with breast cancer has revealed that three-year mammographic screening is insufficient for around half of all women who could be candidates for annual screening. This is good news for regions where annual screening is the norm as it suggests a potential saving by screening less frequently in one subgroup, but perhaps less welcome news in countries such as the UK where three-year screening is recommended.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content